Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Neurology

How Does Diabetes Affect Charcot-Marie-Tooth Type 1A?

At a Glance

Diabetes acts as a "second hit" to nerves already vulnerable from Charcot-Marie-Tooth disease type 1A (CMT1A). High blood sugar accelerates nerve loss, worsens numbness and weakness, and increases the risk of foot ulcers. Managing blood sugar is critical to protecting remaining nerve function.

Having Charcot-Marie-Tooth disease type 1A (CMT1A) means your peripheral nerves are already vulnerable due to a genetic mutation. If you develop diabetes or high blood sugar, it can act as a “second hit” to these delicate nerves [1]. High blood sugar causes its own type of nerve damage known as diabetic neuropathy. When diabetic neuropathy occurs on top of the existing damage from CMT1A, it accelerates the loss of nerve fibers, impairs nerve regeneration, and drastically worsens symptoms like muscle weakness and numbness [1].

The “Second Hit” to Your Nerves

To understand why your doctor wants you to be extra careful about your blood sugar, it helps to look at how these two conditions affect your nerves differently:

  • CMT1A’s Impact: CMT1A primarily affects the myelin sheath—the protective insulation around your nerve fibers (axons) [2]. Because the insulation is faulty, nerve signals travel slower, and over time, the underlying nerve fibers can become damaged.
  • High Blood Sugar’s Impact: Chronic high blood sugar damages the tiny blood vessels that supply oxygen and nutrients to your nerves. It also causes oxidative stress and metabolic dysfunction (cellular damage and energy problems), directly injuring the nerve fibers themselves [3][4].

When you have both conditions, your nerves face a “double hit.” Studies show that patients with CMT1A and co-existing diabetes (or even impaired glucose tolerance, often called prediabetes) experience a severe worsening of both daily symptoms and underlying nerve damage [1]. This disrupts how the nerve fiber and its protective coating support each other, leading to an increased loss of nerve fibers [1].

How Symptoms Can Change

If high blood sugar begins affecting your nerves alongside CMT1A, the first and most common change is a rapid worsening of your existing distal symptoms (numbness and weakness in your hands and feet). In addition to this, medical research notes that people with both CMT1A and glucose metabolism disorders often develop proximal weakness (weakness in the muscles closer to the center of the body, like the thighs or upper arms), which is less common in typical CMT1A [5].

Furthermore, diabetic neuropathy often causes burning pain, tingling, or a “stocking-glove” pattern of numbness in the hands and feet. Because both conditions can lead to reduced sensation in your feet, you are at a much higher risk for developing slow-healing foot sores or plantar ulcers [6].

Protecting Your Nerves

While you cannot change the genetic mutation that causes CMT1A, your blood sugar is something you and your medical team can manage.

  • Monitor Your Blood Sugar: Regular screenings, such as an HbA1c test (which measures your average blood sugar over three months), are crucial. Catching elevated blood sugar early allows you to intervene before it causes significant nerve damage.
  • Comprehensive Management: If you are diagnosed with diabetes, aggressive management of your glucose levels—through medication, diet, and exercise—is considered highly beneficial for preventing further progression of neuropathy and avoiding severe complications [6].
  • Daily Foot Checks and Podiatry: Because of the compounding numbness from both conditions, inspect your feet daily for any cuts, blisters, or pressure sores. Establishing care with a podiatrist for professional foot care and custom orthotics is a critical preventative step.

By keeping your blood sugar in a healthy range, you are actively protecting your vulnerable nerves from unnecessary additional damage.

Common questions in this guide

Why is high blood sugar especially dangerous for someone with CMT1A?
High blood sugar causes its own type of nerve damage called diabetic neuropathy. In someone with CMT1A, whose nerves are already vulnerable from faulty myelin insulation, this creates a double hit that accelerates nerve fiber loss and drastically worsens symptoms.
What new symptoms might I experience if I develop diabetes with CMT1A?
You may notice a rapid worsening of your usual numbness and weakness in your hands and feet. You might also develop new weakness closer to the center of your body, like in your thighs or upper arms, along with burning pain or tingling.
How often should I be tested for diabetes if I have Charcot-Marie-Tooth?
Because high blood sugar significantly worsens CMT1A nerve damage, regular screenings like an HbA1c test are crucial. You should discuss a screening schedule with your doctor to catch elevated blood sugar early before it causes additional nerve injury.
Why do I need to see a podiatrist if I have both CMT1A and diabetes?
Both conditions reduce sensation in your feet, putting you at a much higher risk for developing dangerous, slow-healing foot sores or plantar ulcers. A podiatrist can provide professional foot care, monitoring, and custom orthotics to protect your feet.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my CMT1A diagnosis, how often should I be screened for diabetes or prediabetes?
  2. 2.What is my current HbA1c, and what target range should I aim for to protect my nerves?
  3. 3.If my blood sugar begins to creep up, what early interventions do you recommend before starting medication?
  4. 4.Should I see a podiatrist regularly to help monitor for and prevent foot ulcers given my compounding risk?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.

    Chao HC, Chou CT, Lee YC, Lin KP

    Journal of the neurological sciences 2015; (358(1-2)):213-20.

    PMID: 26349404
  2. 2

    Monitoring Myelin Lipid Composition and the Structure of Myelinated Fibers Reveals a Maturation Delay in CMT1A.

    Capodivento G, Camera M, Liessi N, et al.

    International journal of molecular sciences 2024; (25(20)) doi:10.3390/ijms252011244.

    PMID: 39457026
  3. 3

    Effect of silver doping on antidiabetic and antioxidant potential of ZnO nanorods.

    Robkhob P, Ghosh S, Bellare J, et al.

    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 2020; (58()):126448 doi:10.1016/j.jtemb.2019.126448.

    PMID: 31901726
  4. 4

    Phenolics Extracted from Jasminum sambac Mitigates Diabetic Cardiomyopathy by Modulating Oxidative Stress, Apoptotic Mediators and the Nfr-2/HO-1 Pathway in Alloxan-Induced Diabetic Rats.

    Umar U, Ahmed S, Iftikhar A, et al.

    Molecules (Basel, Switzerland) 2023; (28(14)) doi:10.3390/molecules28145453.

    PMID: 37513325
  5. 5

    High glucose level as a modifier factor in CMT1A patients.

    Secchin JB, Leal RCC, Lourenço CM, et al.

    Journal of the peripheral nervous system : JPNS 2020; (25(2)):132-137 doi:10.1111/jns.12379.

    PMID: 32347995
  6. 6

    Diabetes coexistent with Charcot-Marie-Tooth disease presenting as a recurrent foot ulcer misdiagnosed as diabetic foot: A case report.

    Yan Z, Chen D, Yao L, et al.

    Journal of diabetes investigation 2021; (12(11)):2099-2101 doi:10.1111/jdi.13574.

    PMID: 33991180

This page explains the interaction between diabetes and CMT1A for educational purposes only. Always consult your neurologist or endocrinologist for medical advice and blood sugar management.

Get notified when new evidence is published on Charcot-Marie-Tooth disease type 1A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.